TP53 and neoplasm: Moreover, in addition to abrogating the tumor suppressor functions of wild-type TP53, R273H mutant has also been found to acquire new oncogenic activities to promote cancer, including metastasis promotion and increased resistance to anticancer treatments [42, 43].